Panel A shows a cross-section of a normal heart (top) and an endomyocardial biopsy sample from a normal heart (bottom; with hematoxylin and eosin staining) that shows normal histologic characteristics ...

For people with obstructive hypertrophic cardiomyopathy (HCM) whose symptoms don’t improve with medication, surgical options like septal myectomy or alcohol septal ablation can be life-changing.

Beta-blockers have been the initial treatment for symptomatic obstructive hypertrophic cardiomyopathy (HCM) despite limited evidence of their efficacy. Aficamten is a cardiac myosin inhibitor that ...

If you or a loved one has recently been diagnosed with hypertrophic cardiomyopathy (HCM), you may have questions about what it means for your health and how to manage the condition. Understanding ...

Learn which common medications you need to avoid when you have oHCM, including some for blood pressure and erectile ...

MINNEAPOLIS — Readouts of data on an experimental drug for hypertrophic cardiomyopathies showed the agent appeared safe and effective in long-term treatment and can significantly improve exercise ...

In one of two trials that substantially expand clinical evidence with myosin inhibitors in the treatment of hypertrophic cardiomyopathy (HCM), a next-in-class agent beat beta-blockers in first-line ...

Living with any kind of heart-related disease can be worrisome, especially one with a range of symptoms, such as obstructive hypertrophic cardiomyopathy (HCM). This genetic condition causes a ...

Credit: Cytokinetics. Myqorzo is supplied in 4 tablet strengths: 5mg, 10mg, 15mg, and 20mg. Due to the risk of heart failure, Myqorzo is available only through a restricted program called the Myqorzo ...

Please provide your email address to receive an email when new articles are posted on . Aficamten improved peak oxygen uptake at 24 weeks vs. metoprolol in patients with obstructive hypertrophic ...